Thierry Tidiane Diagana

9PUBLICATIONS
82CO-AUTHORS
Infant and child healthChemotherapyTraditional Chinese medicine and treatmentsMajor global burdens of diseaseNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 27, 2026
Development of a Phase 1 Cryptosporidiosis Controlled Human Challenge Model in Healthy Volunteers Using Current Good Manufacturing Practice Cryptosporidium Parvum Oocysts and Conducted Under an Investigational New Drug Application.

|Feb 18, 2026
Development of a current Good Manufacturing Practice-compliant Process for Producing Cryptosporidium parvum oocysts for Clinical Use.

Rajiv S Jumani, Bryanna Thomas, Jay Lakshman

|Oct 08, 2024
Cryptosporidium PI(4)K inhibitor EDI048 is a gut-restricted parasiticidal agent to treat paediatric enteric cryptosporidiosis.

Ujjini H Manjunatha, Suresh B Lakshminarayana, Rajiv S Jumani

|Jun 29, 2023
Cyanotriazoles are selective topoisomerase II poisons that rapidly cure trypanosome infections.

Srinivasa P S Rao, Matthew K Gould, Jonas Noeske

|Mar 11, 2021
Use-case scenarios for an anti-Cryptosporidium therapeutic.

Paul G Ashigbie, Susan Shepherd, Kevin L Steiner

|Feb 04, 2021
NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models.

Stephanie A Moquin, Oliver Simon, Ratna Karuna

Pageof 2

Frequent Collaborators

5 joint publications

Ujjini H Manjunatha

4 joint publications

Suresh B Lakshminarayana

3 joint publications

Annemarie Voorberg-van der Wel

3 joint publications

Guglielmo Roma